# Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/catalytic-mtor-inhibitors-can-overcome-intrinsic-and-acquired-resistance-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | B. Hassan,Argun Akçakanat,Takafumi Sangai,Kurt W. Evans,Farrell Adkins,Agda Karina Eterovic,Hao Zhao,Ken Chen,Huiqin Chen,Kim‐Anh Do,Shelly M. Xie,Ashley M. Holder,Aung Naing,Gordon B. Mills,Funda Meric‐Bernstam |
| Citations | 61 |
| DOI | 10.18632/oncotarget.2337 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/2337/pdf/ |
| OpenAlex ID | https://openalex.org/W2119607485 |
| PMID | 25261369 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Farrell Adkins](https://scholariq.org/researchers/farrell-adkins/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.